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Edited by Judit Ova´diAbstract Binding of MgATP to an allosteric site ofEscherichia
coli phosphofructokinase-2 (Pfk-2) provoked inhibition and a di-
mer–tetramer (D–T) conversion of the enzyme. Successive dele-
tions of up to 10 residues and point mutations at the C-terminal
end led to mutants with elevated KMapp values for MgATP which
failed to show the D–T conversion, but were still inhibited by the
nucleotide. Y306 was required for the quaternary packing in-
volved in the D–T conversion and the next residue, L307, was
crucial for the ternary packing necessary for the catalytic
MgATP-binding site. These results show that the D–T conver-
sion could be uncoupled from the conformational changes that
lead to the MgATP-induced allosteric inhibition.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Substrate inhibition induced by MgATP is an extended char-
acteristic of phosphofructokinases characterized from diﬀerent
sources. In Escherichia coli, two non-homologues phosphofr-
uctokinases, Pfk-1 and Pfk-2 [1], have been described to show
MgATP-induced substrate inhibition [2–5]. In the case of Pfk-
2, this enzymatic inhibition has been related with the presence
of an allosteric site for the nucleotide [3], a relevant feature,
since E. coli strains that express a non-inhibited form of the en-
zyme presented a diminished growth rate in gluconeogenic
media [6].
The quaternary structure of the free form of Pfk-2 has been
described as a permanent homodimer whose aggregation state
is an obligated conformation necessary for catalysis and stabil-
ity [7,8]. However, the fact that the presence of MgATP
favored the tetrameric form of the enzyme [1,2] prompted
the idea that the dimer is the active form of Pfk-2 and the tet-
ramer the inhibited one [9,10]. Nevertheless, the precise role of
the tetramer in the inhibition mechanism is still unknown,
mainly because of the absence of a model that describes theAbbreviations: Pfk-2, phosphofructokinase-2; Rh, hydrodynamic ra-
dius; KMapp, apparent Michaelis–Menten constant; kcat, catalytic
constant; fructose-6-P, fructose-6-phosphate
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doi:10.1016/j.febslet.2008.05.011kinetics of substrate inhibition on the one hand, and the ab-
sence of structural support for the biochemical data on the
other.
Binding of MgATP to the free enzyme (measured by ﬂuores-
cence titration) has been interpreted as an allosteric binding
[10] because the kinetic mechanism of addition of substrates
predicts that MgATP binding to the active site is forbidden
in the absence of fructose-6-phosphate (fructose-6-P) [11]. In
this regard, a fragment of Pfk-2 obtained by limited proteolysis
retained the allosteric-binding capacity, as indicated by ﬂuo-
rescence titration experiments performed in presence of
MgATP, but was not able to form tetramers [12]. Since the
Pfk-2 fragment was characterized as a 28 kDa polypeptide
with an intact N-terminal sequence, it was suggested that res-
idues from C-terminal region are important for the MgATP-
induced tetramerization [12]. However, the relationship be-
tween tetramer formation and the MgATP-induced inhibition
of the enzyme could not be addressed since the Pfk-2 fragment
was inactive.
Pfk-2 belongs to the ribokinase superfamily [13], an exten-
sive family of kinases that phosphorylates a broad range of
vitamins and sugars [14]. In this family, the active sites are
mostly contained in a structurally conserved a/b/a-fold and
the structural determinants for the nucleoside phosphate do-
nors binding, ATP or ADP, are located at the C-terminal re-
gion of this fold [14,15]. Thus, besides the Pfk-2 inactivation
provoked by the proteolytic digestion, structural alterations
of the catalytic MgATP-binding site can be predicted to occur
upon limited proteolysis of the C-terminal end of enzyme.
In this work, we have performed successive C-terminal dele-
tions and point mutations in Pfk-2 in order to characterize the
structural determinants of the catalytic ATP-binding site and
the structural determinants of the MgATP-induced dimer–tet-
ramer conversion, whose localization at the C-terminal region
is predicted by the limited proteolysis experiments mentioned
above. The C-terminal mutants were evaluated with respect
to their kinetic parameters, sensitivity towards MgATP inhibi-
tion and aggregation state. Finally, the results are discussed in
the light of the crystal structure of Pfk-2 obtained recently by
our group [PDB ID, 3CQD].2. Materials and methods
2.1. Site-directed mutagenesis; mutants expression and puriﬁcation
Site-directed mutagenesis was carried out using the GeneTailor
Site-Directed Mutagenesis System (Invitrogen) using a pET21d plas-
mid (Novagen) containing the pfk-2 gene as template. Oligonucleotides
encoding stop codons were used to introduce new translational stopblished by Elsevier B.V. All rights reserved.
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mutations were veriﬁed by DNA sequencing of both strands. The mu-
tant Pfk-2 enzymes were produced in E. coli Bl21 (DE3). Wild-type
and mutant enzymes were puriﬁed as described by Parducci et al.
[16]. However, the D299 mutant could not be puriﬁed because of its
poor binding to the Cibacron Blue-Sepharose column. In this case,
the overexpressed mutant represents about 80% of the total protein,
so its kcat values were corrected accordingly.
2.2. Size exclusion chromatography
Experiments were performed with a Waters 1525 HPLC binary
pump system, with a Bio-Sil SEC-250 (7.8 mm · 30 cm) column (Bio-
Rad, Hercules, CA, USA) equilibrated in a buﬀer containing 25 mM
Tris–HCl, pH 7.6, 200 mM KCl and 1 mM dithiotreitol at the indi-
cated Mg2+, ATP and fructose-6-P concentrations. Protein elutionFig. 1. Successive C-terminal residue deletions of Pfk-2. The
C-terminal end a-helix of Pfk-2 is represented with the primary
sequence expected for each mutant used in this study.
Table 1
Kinetic parameters measured for the wild-type enzyme and the
C-terminal deletion mutants
Wild-type L307 Y306 A305 D299
KMapp fructose-6-P
(lM)a,b
57 ± 3 60 45 36 20
KMapp MgATP (lM)
a 15 ± 3 10 880 800 2000
kcat (s
1)c 58 ± 3 46 38 35 4
aDeterminations performed with 1 mM co-substrate.
bThe concentration of the co-substrate was chosen in order avoid the
eﬀect of MgATP binding at the allosteric site to the binding of fruc-
tose-6-P to the catalytic site, which is observed above 1 mM MgATP
(unpublished observations).
cDeterminations performed as a function of the MgATP concentration
with 1 mM fructose-6-P.
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Fig. 2. Activity of the Y306 and A305 mutants as a function of the MgA
function of the MgATP concentration using a ﬁxed concentration of 2 mM
and A305 mutant (panel B).was recorded with the use of an online Waters 2487 UV dual detector.
All runs were carried out at a ﬂow rate of 0.8 ml/min. The column was
calibrated with the following molecular-mass markers: Vitamin B-12
(1.35 kDa, 8.5 A˚ hydrodynamic radius, Rh), horse myoglobin
(17 kDa, 19 A˚ Rh), chicken ovalbumin (44 kDa, 30.5 A˚ Rh), bovine
gamma globulin (158 kDa, 41.8 A˚ Rh) and bovine thyroglobulin
(670 kDa, 85 A˚ Rh). Protein elution volumes were converted to Rh val-
ues using the linear relationship obtained with the molecular-mass
markers,
Rh ¼ 51:8
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
 logKav
p
 9:5
Kav ¼ V e  V o
V t  V o
 
where Kav represents the partition constant calculated from the elu-
tion volume (Ve), the void volume (Vo) and the total volume of the col-
umn (Vt) [17].
2.3. Enzyme assays
Phosphofructokinase activity was determined spectrophotometri-
cally by coupling the fructose-1,6-bisphosphate production to the oxi-
dation of NADH [1]. The assay was slightly modiﬁed to avoid a kinetic
lag observed at the initial time of the measurements. Decreasing the
Tris–HCl concentration from 100 to 25 mM together the omission of
NHþ4 salt from the assay mixture, eliminates the kinetic lag that com-
plicates the initial velocity measurements at low substrate concentra-
tions, but does not modify the regulatory properties and the kcat
values of Pfk-2. The apparent KM value (KMapp) for MgATP was cal-
culated by using an uncompetitive substrate inhibition function, and
the KMapp for fructose-6-P by using a non-linear curve ﬁt to a hyper-
bolic function. The ﬁt procedure was performed by a non-linear regres-
sion tool provided by the Sigmaplot package 9.0 (SYSTAT Software
Inc).3. Results
3.1. Dimer–tetramer conversion induced by MgATP and kinetic
characterization of the mutants generated by successive
removal of residues from the C-terminal end
Four mutants with 2–10 residues deletions from the Pfk-2
C-terminal end (Fig. 1) were characterized with respect to
their apparent KM values for fructose-6-P, MgATP and their
catalytic constants (kcat). Compared to the wild-type enzyme,
all mutants, with the exception L307, presented increased0 2 4 6 8 10
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TP concentration. Each panel shows the initial velocity measured as
(n), 0.2 mM () and 0.05 mM () fructose-6-P. Y306 mutant (panel A)
M. Baez et al. / FEBS Letters 582 (2008) 1907–1912 1909KMapp values for MgATP without signiﬁcant changes in the
apparent KM values for fructose-6-P (Table 1). Deletion of
three residues (mutant Y306) resulted in a 1.5 orders of
magnitude increase of the KMapp value for MgATP, with re-
spect to the L307 mutant and the wild-type enzyme. The
elimination of L307 seems to be necessary and suﬃcient to
provoke a large alteration in the pseudo-aﬃnity for MgATP,
since subsequent deletion of four residues (mutant A305) and
10 residues (mutant D299) lead to a progressive increase,
from 1.5 to 1.8 orders of magnitude, of the KMapp value
for MgATP (Table 1). Among the characterized mutants,
only Y306 and A305 show a speciﬁc alteration in their KMapp
value for MgATP since both mutants retain about the 80% of
the wild-type activity without variations of the KMapp forRh, Å
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Fig. 3. Eﬀect of MgATP in the agregation state of the wild-type
enzyme and the C-terminal mutants. Each panel represents the elution
proﬁle of the proteins obtained from a size exclusion chromatography
with the column equilibrated without MgATP (segment lines) or with
0.2 mM MgATP (continuous line). The Rh value obtained for each
protein is shown into each the panel with (left) or without MgATP
(right).fructose-6-P (Table 1). Further elimination of up to 10 resi-
dues provokes a decrease of the enzymatic activity to 10%
of the value of the wild-type enzyme (Table 1).
Substrate inhibition induced by MgATP is a property of the
wild-type enzyme that has been related with the presence of an
allosteric site that negatively regulates the enzymatic activity of
Pfk-2 [3,10]. Fig. 2 shows the initial velocity of mutants Y306
and A305 measured as a function of the MgATP concentration
by using several ﬁxed concentrations of fructose-6-P. As can be
seen, the enzymatic activity goes through a maximum value
and then decreases at elevated concentrations of MgATP, indi-
cating that the allosteric inhibition induced by MgATP is still
operative, although the KMapp value for the nucleotide of both
mutants was about 1.5 orders of magnitude higher than the
wild-type enzyme.
To determine the eﬀect of the C-terminal deletions in the
MgATP-induced tetramer formation, size exclusion chroma-
tography was performed in the presence of 0.2 mM MgATP.
As shown in Fig. 3, with the exception of the L307 mutant that
presents a wild-type phenotype, neither mutant modiﬁed sig-
niﬁcantly its Rh in the presence of 0.2 mMMgATP, suggesting
that the structural alterations that resulted in an elevated
KMapp for MgATP are linked with the tetramer formation in-
duced by MgATP binding at the allosteric site. In absence of
MgATP the hydrodynamic radiuses of the C-terminal mutants
(Y306, A305 and D299) show a slight increment, between 0.6
and 1 A˚ with respect the value observed for the wild-type di-
mer (see Fig. 3). Although the observed size increments could
be due to alterations in the shape of the mutants or to incre-
ments in the tetramer populations, the latter seems unlikely
since the dimer–tetramer conversion does not take place in
the wild-type enzyme in absence of MgATP [8].
The impediment of those mutants to form tetramers in pres-
ence of MgATP, as Y306 and A305, seems not to be related
with the enzymatic inhibition induced by MgATP, since both
mutants show this feature when the initial velocity is assayed
at elevated concentrations of the nucleotide (Fig. 2). In order
to study the failure in tetramer formation in a kinetic back-
ground closer to the wild-type, the side chains of L307 and
Y306 were replaced by alanine to generate the point mutants
Y306A and L307A.3.2. Dimer–tetramer conversion induced by MgATP and kinetic
properties of the Y306A and L307A mutants
The MgATP-induced inhibition of Pfk-2 has been described
as a biphasic behavior of the initial velocity, measured as func-
tion of the MgATP concentration, when the assay was per-
formed at low fructose-6-P concentrations (0.1 mM); which
tended to become hyperbolic at elevated concentrations
(1 mM) [2,3]. Fig. 4 shows the initial velocity as a function
of the MgATP concentration for the wild-type enzyme and
the Y306A and L307A mutants using two ﬁxed concentrations
of fructose-6-P. At 1 mM fructose-6-P (Fig. 4A), the KMapp for
MgATP for the L307A mutant was about 1.5 orders of mag-
nitude higher than the wild-type enzyme while the kcat and
KMapp for fructose-6-P remain essentially unchanged (Table
2). At 0.1 mM fructose-6-P (Fig. 4B) the MgATP-induced inhi-
bition is favored since a decrease of the initial velocity is ob-
served at elevated concentrations of the nucleotide. As
shown, the L307A mutant presents its activity maximum at
higher MgATP concentrations compared to the wild-type
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Fig. 4. Dependence of the initial velocity on the MgATP concentrations for wild-type Pfk-2 and the L307A and Y306A mutants. Each panel shows
the initial velocity of the L307A mutant (h), Y306A mutant () and the wild-type enzyme (n) as function of the MgATP concentration by using ﬁxed
concentrations of 2 mM (panel A) and 0.1 mM (panel B) fructose-6-P. The concentration of MgATP is shown in a logarithmic scale.
Table 2
Kinetic parameters measured for the wild-type enzyme and the Y306A
and L307A mutants
Wild-type Y306A L307Ab
KMapp fructose-6-P (lM)
a 57 ± 3 62 ± 11 29
KMapp MgATP (lM)
a 15 ± 3 13.7 ± 0.9 954
kcat (s
1)c 58 ± 3 53 ± 3.7 59
aDeterminations performed with 1 mM co-substrate.
bAverage of two measurements.
cDeterminations performed as a function of the MgATP concentration
with 1 mM fructose-6-P.
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Fig. 5. Eﬀect of MgATP in the hydrodynamic radius (Rh) of the wild-
type enzyme and the Y306A mutant. Elution proﬁles of the wild-type
enzyme (dashed line) and the Y306A mutant (continuous line) were
obtained by using a size exclusion column equilibrated with 0.8 mM
MgATP. The Rh of each species is indicated in the ﬁgure.
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MgATP; the inhibition is still observed although at higher con-
centrations of the nucleotide. As pointed out above, the C-ter-
minal deletion mutants, characterized by elevated KMapp
values for MgATP, were unable to form tetramers in presence
of MgATP. The same situation is observed with the L307A
mutant when injected to a size exclusion column in the pres-
ence of 0.2 mM MgATP (data not shown). Thus, the origin
of the conformational change that leads to an increase in the
KMapp value for MgATP and the impairment in tetramer for-
mation can be mapped to the side chain of L307.
On the other hand, the change of Y306 by alanine does not
modify the KMapp value for MgATP and the other kinetic
parameters compared to the wild-type enzyme (Fig. 4A and
Table 2). This result seems reasonable since the L307 side
chain is present in the protein. However, size exclusion chro-
matography performed with the Y306A mutant did not show
the presence of a tetrameric species even at 0.8 mM MgATP
(Fig. 5). Therefore, the side chain of Y306 seems crucial for
the MgATP-induced dimer–tetramer conversion, but is not re-
quired for the MgATP binding at the active site, as can be de-
duced from its unaltered KMapp value. Moreover, since the
MgATP-induced inhibition of the enzymatic activity observed
in the Y306A mutant was also unmodiﬁed with respect to the
inhibition pattern of the wild-type (Fig. 4B), the dimer–tetra-
mer conversion seems not to be a requirement for the allosteric
inhibition of the Y306A mutant.4. Discussion
4.1. Eﬀect of the successive C-terminal deletions on the kinetic
parameters of Pfk-2
Despite of the low sequence identity among the members of
the ribokinase superfamily, the nucleotide-binding site is a
structurally conserved feature [14,15]. Speciﬁcally, the adenine
ring of the phosphate donor appears into a hydrophobic pock-
et created by two loops, the small and large ATP-binding
loops, in the ribokinase fold [18]. Fig. 6 shows the C-terminal
portion of the crystallographic structure of Pfk-2 where the
last segment of eleven residues form an amphipathic a-helix
whose hydrophobic side chains are in close contacts with the
large ATP-binding loop atoms and with a structurally con-
Fig. 6. Relevant structural features of the C-terminal end of Pfk-2. Right: Pfk-2 tetramer [PDB ID, 3CQD]. One homodimer is shown as surface
while the other is shown as a cartoon. The portion of the surface drawn dimer in contact with the other dimer is colored based on the DDGbind
obtained by the alanine scanning (see Section 4). The catalytic ATP is shown as yellow sticks. The square marks the region highlighted in the left side
of the ﬁgure. Upper left: tertiary packing of the C-terminal portion of the ATP-binding site. The backbone is shown with ribbon cartoons; the side
chains of I303, Y306, and L307 are shown as sticks and surfaces, while the ATP molecule located in the active site is shown as balls and sticks.
Bottom left: quaternary packing of the C-terminal region of Pfk-2. The ﬁgure shows the contact between Y306 of one dimer with the other dimer.
The ﬁgure was prepared using the VMD software [24].
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binding site in the ribokinase superfamily members. Particu-
larly, L307 is the last hydrophobic residue of the amphipathic
a-helix whose apolar side chain is buried with atoms of the
large ATP loop and of the conserved a-helix (Fig. 6). This fea-
ture correlates well with the abrupt increase of 1.5 orders of
magnitude of the KMapp value for MgATP that occurs upon
deletion of a three residue segment that includes L307 (mutant
Y306) or by a point mutation that replaces its side chain by
alanine (mutant L307A). It is known that cavities created by
substituting apolar buried side chains by apolar smaller ones,
provoke structural rearrangements driven by an unfavorable
loss of contacts in hydrophobic cores [19]. The structural rear-
rangements induced by ‘‘cavity-creating’’ mutants, Y306 and
L307A, seems to aﬀect mostly the tertiary packing around
the ATP-binding loop since, besides the large increment in
the KMapp value for MgATP, no signiﬁcant changes were ob-
served in the KMapp for fructose-6-P or kcat values in these mu-
tants.
Chinese hamster adenosine kinase is a monomeric member
of the ribokinase superfamily that shares a 12% sequence iden-
tity with Pfk-2, but presents a good alpha carbons structuralsuperposition (1.7 A˚ R.M.S). Maj and coworkers [20] have
performed successive deletions of the C-terminal region of
adenosine kinase reporting a gradual decrease of the kcat value
together with a progressive increase of the KMapp for MgATP,
while the KMapp value for the adenosine phosphate acceptor
was unaltered, independent of number of deleted residues.
Likewise, the KMapp of the phosphate acceptor of Pfk-2 (fruc-
tose-6-P) is maintained with the number of deleted residues,
suggesting that conformational changes at the C-terminal re-
gion of the ATP-binding site can be uncoupled from the phos-
phate acceptor-binding site in the ribokinase fold. However, in
contrast with the abrupt increase of 1.5 orders of magnitude
observed upon deletion of L307 in Pfk-2, in adenosine kinase
the KMapp value for MgATP suﬀers a gradual increase with
the number of deleted residues. The superposition of both
structures shows that the deleted residues, in the case of aden-
osine kinase, form a loop whose side chains do not show direct
contacts with atoms involved in the ATP-binding site [21].
Conversely, the hydrophobic side chains of the amphipathic
a-helix in Pfk-2 are packed against atoms of the ATP loop
and with a helix that forms part of the adenosine-binding moi-
ety (Fig. 6A).
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MgATP-induced tetramer formation
A striking characteristic of the C-terminal mutants is that,
besides their elevated KMapp for MgATP, they present impair-
ment in the MgATP-induced tetramer formation. The biologic
unit of Pfk-2 present into the crystal structure obtained in the
presence of MgATP was assumed to be a homotetramer cre-
ated by a surface of interaction that hides an extensive area
of 2154 A˚2 for each dimer (unpublished data). Despite of this
extensive contact area, only 4 side chains are expected to de-
crease the free energy of subunit interaction (DDGbind) by at
least 1.2 kcal/mol upon alanine replacement. This value was
predicted by using an in silico alanine scanning method [22]
available in the Web (http://robetta.bakerlab.org/alaninescan).
Between the selected side chains, Y306 presents a calculated
DDGbind of 4.4 kcal/mol (1.15 kcal/mol per subunit). As shown
in Fig. 6, Y306 is the only modiﬁed residue in this work whose
side chain makes contact with the adjacent homodimer. This
suggests that the same conformational change that is responsi-
ble for the increased KMapp value for MgATP, upon replace-
ment or deletion of L307, could modify the correct
orientation of the Y306 side chain, which in turn could explain
the failure of the dimer–tetramer conversion observed in the
‘‘cavity-creating’’ mutants. In agreement with this idea, the
replacement of Y306 by alanine generates a mutant unable
to form tetramers, but with a kinetic behavior almost invariant
with respect to the wild-type enzyme. The importance of this
result is the indication that conformational changes that lead
to allosteric inhibition can be uncoupled from tetramer forma-
tion at least in the case of the Y306A mutant. For the wild-
type enzyme, Cabrera and coworkers [23] reported that, be-
sides tetramer formation, the presence of MgATP promotes
subunit conformational changes, deﬁned as rigid movements
between the mayor and the minor domains, which result in
the closure of the active site of each subunit. Therefore, taking
into account that in presence of MgATP the mutant Y306A
does not show the dimer–tetramer conversion but presents
an inhibition pattern almost undistinguishable from the wild-
type enzyme, the enzymatic inhibition induced by MgATP
can be explained exclusively by conformational changes at
the dimeric or monomeric level of Pfk-2. Further experiments
are required to determine the biologic relevance of the dimer–
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